p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
2000

Detecting p53 Mutations in Bladder Cancer Samples

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): Phillips H A, Howard G C W, Miller W R

Primary Institution: Department of Clinical Oncology, University of Edinburgh, Western General Hospital, Edinburgh, UK

Hypothesis

Can p53 mutations be detected in bladder washing samples from patients with bladder cancer?

Conclusion

The study found that p53 mutations can be detected in bladder-washing samples from patients with bladder cancer.

Supporting Evidence

  • An abnormal SSCP band was detected in five samples from five different patients.
  • The same abnormal SSCP pattern was demonstrated in samples of the corresponding bladder tumour.
  • In one case, bladder washings were available from the same patient on two separate occasions.

Takeaway

Doctors can find cancer genes in urine samples from bladder cancer patients, which might help them avoid more invasive tests.

Methodology

The study used single-stranded conformational polymorphism (SSCP) analysis to detect mutations in the p53 gene in bladder-washing specimens.

Limitations

The study is a pilot and may not represent larger populations.

Participant Demographics

Patients with bladder cancer (27 patients, 31 samples).

Digital Object Identifier (DOI)

10.1054/bjoc.1999.0890

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication